ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity an human mammary epithelial cells

British Journal of Cancer

Volumn 82, Issue 3, 2000, Pages 666-674

  Woods Ignatoski, K M ^a   Maehama, T ^a   Markwart, S M ^a   Dixon, J E ^a   Livant, D L ^a   Ethier, S P ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

ERBB 2; Human breast cancer; Human mammary epithelial cells; Invasion; P13' kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CELL SURFACE PROTEIN; FIBRONECTIN; FOCAL ADHESION KINASE; INTEGRIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE INHIBITOR;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CELL INVASION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN INTERACTION;

EID: 0000446084     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0979     Document Type: Article

References (53)

1. Akiyama SK and Yamada KM (1985) The interactions of plasma fibronectin with fibroblastic cells in suspension. J Biol Chem 260: 4492-4500
2. Alroy I and Yarden Y (1997) The erbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligan-receptor interactions. FEBS Lett 410: 83-86
3. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan X-Y, Sauter G, Kallioniemi O-P, Trent JM and Meltzer PS (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965-968
4. Aota S, Nomizu M and Yamada KM (1994) The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell adhesive function. J Biol Chem 269: 24756-24761
5. Bachelot C, Ramesh L, Parsons T and Cantley LC (1996) Association of phosphatidylinositol 3-kinase, via the SH2 domains of p85, with focal adhesion kinase in polymoma middle t-transformed fibroblasts. Biochimica et Biophisica Acta 1311: 45-52
6. Band V and Sager R (1989) Distinctive traits of normal and tumor derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci USA 86: 1249-1253
7. Band V, Zajchowski D, Swisshelm D, Trask D, Kulesa V, Cohen C, Connolly J and Sager R (1990) Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res 50: 7351-7357
8. Benlevy R, Paterson HF, Marshall CJ and Yarden Y (1994) A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway. EMBO J 13: 3302-3311
9. Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B and Hynes NE (1988) Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48: 1238-1243
10. Bieche I, Tomasetto C, Regnier CH, Moog-Lutz C, Rio M-C and Lidereau R (1996) Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer. Cancer Res 56: 3866-3890
11. Bonilla M, Ramirez M, Lopez-Cueto J and Gariglio P (1988) In vivo amplification and rearrangement of c-myc oncogene in human breast tumors. J Natl Cancer Inst 80: 665-671
12. Borg A, Baldetorp B, Ferno M, Olsson H and Sigurdsson H (1992) c-myc amplification is an independent prognostic factor in postmenopausal breast cancer. Int J Cancer 51: 687-691
13. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Analytical Biochemistry 72: 248-254
14. Clark RAF, Wikner NE, Doherty DE and Norris DA (1988) Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120 kDa fibroblastic cell binding fragment. J Biol Chem 263: 1215-12123
15. DiFiore PP, Pierce JH, Kraus MH, Segatto O, King CR and Aaronson SA (1987) erbB-2 is a potent oncogene when overexpressed in N1H/3T3 cells. Science 237: 178-181
16. DiFiore PP, Segatto O, Leonardo F, Fazioli F, Pierce JH and Aaronson SA (1990a) The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity. Mol Cell Biol 10: 2749-2756
17. DiFiore PP, Segatto O, Taylor WG, Aaronson SA and Pierce JH (1990b) EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science 248: 79-83
18. Earp HS, Austin KS, Blaisdell J, Rubin RA, Nelson KG, Lee LW and Grisham JW (1986) Epidermal growth factor (EGF) stimulates EGF receptor synthesis. J Biol Chem 261: 4777-4780
19. Fedi P, Pierce JH, Difiore PP and Kraus MH (1994) Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes erbB-3 signaling from that of other erbB EGFr family members. Mol Cell Biol 14: 492-500
20. Gillet CV, Fantl R, Smith C, Fisher J, Bartek C, Dickson D, Barnes and Peters G (1994) Amplification and overexpression of cyclinD1 in breast cancer detected by immunohistochemical staining. Cancer Res 54: 1812-1817
21. Grinnell F, Ho CH and Wysocki AJ (1992) Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Derm 98: 410-416
22. Guan JL (1997) Role of focal adhesion kinase in integrin signaling. Int J Biochem, and Cell Biol 29: 1085-1096
23. Guerin M, Gabillot M, Mathieu MC, Travagli JP, Spielmann NA and Riou G (1989) Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance. Int J Cancer 43: 201-208
24. Harris KF, Christensen JB, Radany EH and Imperiale MJ (1998) Novel mechanisms of E2F induction by BK virus large T antigen: requirement of both the pRb binding and J domains. Mol Cell Biol 18: 1746-1756
25. Hayman EG, Pierschbacher M and Engvall E (1982) Fibronectin: purification, immunochemical properties, and biological activities. Meth Enzymol 82: 803-831
26. Hudziak RM, Schlessinger J and Ullrich A (1987) Increased expression of the putative growth factor receptor p185Her2 causes transformation and tumorigenesis of NIH3T3 cells. Proc Natl Acad Sci USA 84: 7159-7163
27. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z and Damsky CH (1995) Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 129: 867-879
28. Ilic D, Damsky CH and Yamamoto T (1997) Focal adhesion kinase at the crossroads of signal transduction. J Cell Science 110: 401-407
29. Jaakkola S, Salmikangas P, Nylund S, Partanen J, Armstrong E, Pyrhonen S, Lehtovirta P and Nevanlinna H (1993) Amplification of fgfr4 gene in human breast and gynecological cancers. Int J Cancer 54: 378-382
30. Jacquemier J, Adelaide J, Pare P, Penaultllorca F, Planche J, Delapeyriere O and Birnbaum D (1994) Expression of the FGFR1 gene in human breast-carcinoma cells. Int J Cancer 59: 373-378
31. Kraus MH, Popescu NC, Amsbaugh SC and King CR (1987) Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6: 605-610
32. Livant DL, Linn S, Markwart S and Shuster J (1995) Invasion of selectively permeable sea urchin embryo basement membranes by metastatic tumor cells, but not by their normal counterparts. Cancer Res 55: 5085-5093
33. Lonardo F, DiMarco E, King CR, Pierce JH, Segatto O, Aaronson SA and DiFiori PP (1990) The normal erbB-2 product is a atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. New Biol 2: 992-1003
34. Luqmani YA, Graham M and Coombes RC (1992) Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br J Cancer 66: 273-280
35. Maehama T and Dixon JE (1998) The tumor suppressor. PTEN/MMACI, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375-13378
36. Marte BM, Grausporta D, Jeschke M, Fabbro D, Hynes NE and Taverna D (1995) NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells. Oncogene 10: 167-175
37. Natali PG, Nocotra MR, Bigotti A, Venturo I, Slamon DJ, Fendly BM and Ullrich A (1990) Expression of the p185 encoded by Her2 oncogene in normal and transformed human tissues. Int J Cancer 45: 457-461
38. Pierce JH, Arnstein P, DiMarco E, Artrip J, Kraus MH, Lonardo F, DiFiore PP and Aaronson SA (1991) Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene 6: 1189-1194
39. Postlethwaite AE, Keski-Oja J, Balian G and Kang A (1981) Induction of fibroblast chemotaxis by fibronectin: localization of the chemotactic region to a 140,000 molecular weight nongelatin binding fragment. J Exp Med 153: 494-499
40. Ram TG, Dilts CA, Dziubinski ML, Pierce LJ and Ethier SP (1996) Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine phosphorylated erbB-2. Mol Carcinogen 15: 227-238
41. Ram TG and Ethier SP (1996) Phosphatidylinositol 3-kinase recruitment by p185 (erbB-2) and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification. Cell Growth Differ 7: 551-561
42. Roklin OW and Cohen MB (1995) Expression of cellular adhesion molecules on human prostate tumor cell lines. Prostate 26: 205-212
43. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A Laboratory Manual. p 18.45. Cold Spring Harbor Laboratory Press: Cold Spring Harbor.
44. Seftor RE, Seftor EA, Sheng S, Pemberton PA, Sager R and Hendrix MJC (1998) Maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res 58: 5681-5685
45. Sen S, Zhou HY and White RA (1997) A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 14: 2195-2200
46. Seppa HE, Yamada KM, Seppa ST, Silver MH, Kleinman HK and Schiffman E (1981) The cell binding fragment of fibronectin is chemotactic for fibroblasts. Cell Biol Int Rep 5: 13-19
47. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182
48. Soltoff SP, Carraway KL, Prigent SA, Gullick WG and Cantley LC (1994) ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol Cell Biol 14: 3550-3558
49. Tamura M, Gu J, Takino T and Yamada KM (1999) Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differnential involvement of focal adhesion kinase and p130Cas. Cancer Res 59: 442-449
50. Watson PH, Safneck JR, Le K, Dubik D and Shiu RPC (1993) Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. J Natl Cancer Inst 85: 902-907
51. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C and Bissell MJ (1997) Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137: 231-245
52. Witkowski CM, Rabinovitz I, Nagle RB, Affinito KD and Cress AE (1993) Characterization of integrin subunits, cellular adhesion and tumorigenicity of four human prostate cell lines. Cancer Res Clin Oncol 119: 637-644
53. Woods Ignatoski KM, LaPointe AJ, Radany EH and Ethier SP (1999) ErbB-2 overexpression in human mammary epithelial cells confers growth factor independence. Endocrinology 140:3615-3622